Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term susceptibility gene. Found 13 abstracts

Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, Lambrechts D, Despierre E, Barrowdale D, McGuffog L, Healey S, Easton DF, Sinilnikova O, Benitez J, Garcia MJ, Neuhausen S, Gail MH, Hartge P, Peock S, Frost D, Evans G, Eeles R, Godwin AK, Daly MB, Kwong A, Ma ES, Lazaro C, Blanco I, Montagna M, D'Andrea E, Nicoletto MO, Johnatty SE, Kruger S, Jensen A, Hogdall E, Goode EL, Fridley BL, Loud JT, Greene MH, Mai PL, Chetrit A, Lubin F, Hirsh-Yechezkel G, Glendon G, Andrulis IL, Toland AE, Senter L, Gore ME, Gourley C, Michie CO, Song HL, Tyrer J, Whittemore AS, McGuire V, Sieh W, Kristoffersson U, Olsson H, Borg A, Levine DA, Steele L, Beattie MS, Chan S, Nussbaum RL, Moysich KB, Gross J, Cass I, Walsh C, Li AJ, Leuchter R, Gordon O, Garcia-Closas M, Gayther SA, Chanock SJ, Antoniou AC, Pharoah PD. Association Between BRCA1 and BRCA2 Mutations and Survival in Women With Invasive Epithelial Ovarian Cancer. JAMA-Journal of the American Medical Association. 2012 Jan;307(4):382-90.
Brewster BL, Rossiello F, French JD, Edwards SL, Wong M, Wronski A, Whiley P, Waddell N, Chen XW, Bove B, Hopper JL, John EM, Andrulis I, Daly M, Volorio S, Bernard L, Peissel B, Manoukian S, Barile M, Pizzamiglio S, Verderio P, Spurdle AB, Radice P, Godwin AK, Southey MC, Brown MA, Peterlongo P. Identification of fifteen novel germline variants in the BRCA1 3 ' UTR reveals a variant in a breast cancer case that introduces a functional miR-103 target site. Human Mutation. 2012 Dec;33(12):1665-75.
Park DJ, Lesueur F, Nguyen-Dumont T, Pertesi M, Odefrey F, Hammet F, Neuhausen SL, John EM, Andrulis IL, Terry MB, Daly M, Buys S, Le Calvez-Kelm F, Lonie A, Pope BJ, Tsimiklis H, Voegele C, Hilbers FM, Hoogerbrugge N, Barroso A, Osorio A, Giles GG, Devilee P, Benitez J, Hopper JL, Tavtigian SV, Goldgar DE, Southey MC. Rare Mutations in XRCC2 Increase the Risk of Breast Cancer. American journal of human genetics. 2012 Apr;90(4):734-9.   PMCID: PMC3322233
Rebbeck TR, Mitra N, Domchek SM, Wan F, Friebel TM, Tran TV, Singer CF, Tea MK, Blum JL, Tung N, Olopade OI, Weitzel JN, Lynch HT, Snyder CL, Garber JE, Antoniou AC, Peock S, Evans DG, Paterson J, Kennedy MJ, Donaldson A, Dorkins H, Easton DF, Rubinstein WS, Daly MB, Isaacs C, Nevanlinna H, Couch FJ, Andrulis IL, Freidman E, Laitman Y, Ganz PA, Tomlinson GE, Neuhausen SL, Narod SA, Phelan CM, Greenberg R, Nathanson KL, Epidemiological Study BB. Modification of BRCA1-Associated Breast and Ovarian Cancer Risk by BRCA1-Interacting Genes. Cancer Research. 2011 Sep;71(17):5792-805.   PMCID: PMC3170727
John EM, Hopper JL, Beck JC, Knight JA, Neuhausen SL, Senie RT, Ziogas A, Andrulis IL, Anton-Culver H, Boyd N, Buys SS, Daly MB, O'Malley FP, Santella RM, Southey MC, Venne VL, Venter DJ, West DW, Whittemore AS, Seminara DG. The Breast Cancer Family Registry: an infrastructure for cooperative multinational, interdisciplinary and translational studies of the genetic epidemiology of breast cancer. Breast Cancer Research. 2004 Jan;6(4):R375-R389.
Daly M, Obrams GI. Epidemiology and risk assessment for ovarian cancer. Seminars in Oncology. 1998 Jun;25(3):255-64.
Liede A, Tonin PN, Sun CC, Serruya C, Daly MB, Narod SA, Foulkes WD. Is hereditary site-specific ovarian cancer a distinct genetic condition?. American Journal of Medical Genetics. 1998 Jan 06;75(1):55-8.
Lynch HT, Casey MJ, Lynch J, White TE, Godwin AK. Genetics and ovarian carcinoma. Seminars in Oncology. 1998 Jun;25(3):265-80.
Ozols RF, Vermorken JB. Chemotherapy of advanced ovarian cancer: Current status and future directions. Seminars in Oncology. 1997 Feb;24(1):S1-S9.
Daly MB, Lerman CL, Ross E, Schwartz MD, Sands CB, Masny A. Gall model breast cancer risk components are poor predictors of risk perception and screening behavior. Breast Cancer Research and Treatment. 1996 Jan;41(1):59-70.
Salazar H, Godwin AK, Daly MB, Laub PB, Hogan WM, Rosenblum N, Boente MP, Lynch HT, Hamilton TC. Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. Journal of the National Cancer Institute. 1996 Dec 18;88(24):1810-20.
Xiao GH, Jin F, Yeung RS. Germ-Line Tsc2 Mutation in a Dominantly Inherited Cancer Model Defines a Novel Family of Rat Intracisternal-a Particle Elements. Oncogene. 1995 Jul 06;11(1):81-7.
Yeung RS, Xiao GH, Jin F, Lee WC, Testa JR, Knudson AG. Predisposition to Renal-Carcinoma in the Eker Rat Is Determined by Germ-Line Mutation of the Tuberous-Sclerosis-2 (Tsc2) Gene. Proceedings of the National Academy of Sciences of the United States of America. 1994 Nov 22;91(24):11413-6.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term susceptibility gene

susceptibility gene risk breast-cancer carcinoma brca1 ovarian-cancer brca1 mutations familial breast germline mutations family registry tumor suppressor gene chromosome-10 participation carriers families mutations animal model cisplatin older women behavior designs sclerosis microrna targets perception rad51 hereditary ovarian cancer women activation palb2 breast cancer nonpolyposis colorectal-cancer encodes dna-repair cells spontaneous transformation screening ovarian carcinoma genome program 2 her-2 prevention polymerase brca2 breast cancer BRCA1-3 ' UTR-microRNAs brca2-interacting protein phase-iii ovulation promoter randomized trial transcriptional site-specific ovarian cancer hereditary cancer candidate binding protein hur suppressor gene tumors history term follow-up dna rearrangement single-nucleotide polymorphism unknown clinical-significance validation maps collaborative analysis united-states ovarian surface epithelium cancer iap element mammography expression haplotype frequencies gynecologic-oncology-group incessant colorectal-cancer white women frequency risk factors states case-control consortium renal-cell carcinoma follow-up BRCA1 low-grade family history bard1 talc protein p53 gene mutation linkage analysis cyclophosphamide carboplatin nonsense oral-contraceptive use progesterone-receptor tumor tuberous long terminal repeats sequence cell carcinoma dna-sequence variants twins insertion dna glycosylase cdna 1995 en cya-trends in biochemical sciences-v20-p465 rad51c human-diseases clinical-trials self-examination eker rat adenomatous polyposis relatives ashkenazi-jewish individuals neu expression mutation carriers cloning 185delAG health Gail model genome-wide association
Last updated on Friday, December 06, 2019